title: Enhancing bowel adaptation in short bowel syndrome.
abstract: Malabsorption of both nonessential and essential nutrients, fluid, and electrolytes will, if not compensated for by increased intake, lead to diminished body stores and to subclinical and eventually clinical deficiencies. By definition, intestinal failure prevails when parenteral support is necessary to maintain nutritional equilibrium. After intestinal resection, adaptation, a progressive recovery from the malabsorptive disorder, may be seen. Research has focused on optimizing remnant intestinal function through dietary or pharmacologic interventions. In this review, factors responsible for the morphologic and functional changes in the adaptive processes are described. Results of clinical trials employing either growth hormone and glutamine or glucagon-like peptide-2 in short bowel patients are presented.
authors.affiliation: Department of Medicine CA-2121, Section of Gastroenterology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100 Copenhagen, Denmark. Bekker@dadlnet.dk
authors.forename: Palle Bekker
authors.initials: PB
authors.lastname: Jeppesen
authors.forename: Per Brobech
authors.initials: PB
authors.lastname: Mortensen
mesh_terms: D000222:Adaptation, Physiological; D003082:Colectomy / Q000009:adverse effects* / Q000379:methods; D005260:Female; D005973:Glutamine / Q000008:administration & dosage*; D013006:Growth Hormone / Q000008:administration & dosage*; D006801:Humans; D007410:Intestinal Diseases / Q000175:diagnosis / Q000601:surgery; D007421:Intestine, Small / Q000601:surgery; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D012778:Short Bowel Syndrome / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D005973:Glutamine; D013006:Growth Hormone